No evidence of cardiotoxicity during antimalarial treatment with artemether-lumefantrine
- PMID: 10674679
- DOI: 10.4269/ajtmh.1999.61.964
No evidence of cardiotoxicity during antimalarial treatment with artemether-lumefantrine
Abstract
Artemether-lumefantrine is a new fixed antimalarial combination effective against multidrug-resistant falciparum malaria. A prospective electrocardiographic study was conducted in 150 patients receiving artemetherlumefantrine and 50 treated with artesunate-mefloquine. There was no evidence for clinically significant changes in the electrocardiographic intervals and in particular no relationship between plasma concentrations of lumefantrine and QTc prolongation. Artemether-lumefantrine does not have significant cardiac effects at therapeutic doses.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
